From standardization to precision medicine: Evolution of European Leukemianet recommendations in Philadelphia-negative myeloproliferative neoplasms.

Ciftciler R, Haznedaroglu IC

Open source

DOI
10.1016/j.leukres.2026.108303
Published
2026 Sep 3
Container
Leukemia research
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.leukres.2026.108303,
  title = {From standardization to precision medicine: Evolution of European Leukemianet recommendations in Philadelphia-negative myeloproliferative neoplasms.},
  author = {Ciftciler R and Haznedaroglu IC},
  year = {2026},
  journal = {Leukemia research},
  doi = {10.1016/j.leukres.2026.108303},
  url = {https://doi.org/10.1016/j.leukres.2026.108303}
}

RIS

TY  - JOUR
TI  - From standardization to precision medicine: Evolution of European Leukemianet recommendations in Philadelphia-negative myeloproliferative neoplasms.
AU  - Ciftciler R
AU  - Haznedaroglu IC
PY  - 2026
JO  - Leukemia research
DO  - 10.1016/j.leukres.2026.108303
UR  - https://doi.org/10.1016/j.leukres.2026.108303
ER  - 

APA

R, C., & IC, H. (2026). From standardization to precision medicine: Evolution of European Leukemianet recommendations in Philadelphia-negative myeloproliferative neoplasms.. Leukemia research. https://doi.org/10.1016/j.leukres.2026.108303

Source records